Final pitches from AI to robotics to health apps
From 3 p.m. on Tuesday afternoon (12 November), the final of the second important start-up competition will be taking place. For the final pitches in the 2024 MEDICA START-UP COMPETITION, a judging panel made up of businesses, investors and renowned industry experts has selected 12 health start-ups that will present their product solutions in different categories and make their bid for the big prize.
Finalists Saventic Health (Poland), U-Care Medical Srl (Italy) and IQONIC.AI (Germany) are all in on artificial intelligence. Saventic uses AI to detect rare diseases, U-Care to improve clinical outcomes in intensive care units, and IQONIC.AI provides AI-supported dermatology solutions for analysing skin conditions and issuing personalised treatment recommendations based on advanced imaging technology.
The robotics category will be represented in the final by Robota (Italy), Robeauté (France) and Goodbot (Germany). Specifically, Robeauté is supporting the medical profession by supplying neurosurgical micro-robots. Robota offers an automated system for sterilising surgical instruments, while Goodbot provides an innovative pipetting robot.
Doctorderma (Germany), Vertify GmbH (Austria) and PharmaTrail AG (Switzerland) will be presenting their health apps. PharmaTrail develops digital solutions to streamline and optimise clinical trial management with a view to improving efficiency and data accuracy in pharmaceutical research.
AGED Diagnostics (United States), Fepod Oy Ltd (Finland) and Dxcover (United Kingdom) are focussed on laboratory diagnostics. For example, Dxcover will be presenting an innovative liquid biopsy technology for the early detection of cancer via a simple blood test.
Women leaders in healthcare – how to make it
The MEDICA INNOVATION FORUM will also be hosting a session on women leaders in healthcare from 12:15 p.m. on Tuesday 12 November. Women working in the industry will then be welcome to network with female executives. Dr Sulzmaier is particularly looking forward to this: “More women are visible in the healthcare sector – and at MEDICA – than in many other industries, and we want to keep moving forward in this regard.” Svenja Lassen, Managing Director for Germany at Gateway Ventures and founder of the Female Investors Network, will be moderating a panel discussion on female leaders in the health sector from 1 p.m. The panellists will be Nina Wöss, co-founder of Female Founders, Hadas Bitran from Microsoft, Tarushi Ranatunga, responsible for knowledge management at Softmatter in Sri Lanka, and Dr Caroline Fichtner, Principal of the High-Tech Gründerfonds, a public-private venture capital firm supporting start-ups in Germany.
After the panel, several women who have achieved a great deal as founders and inventors will be sharing their solutions and experiences: Dr Anne Latz, co-founder of Hello Inside, Audrey A. Sherman from Solventum (formerly 3M Healthcare) who holds more than 150 patents, and Dr Marie Berthuel, co-founder of BeFC – Bioenzymatic Fuel Cells in France.
Afterwards, there will be the opportunity to join a guided tour covering start-ups and innovation topics. And the “grand finale”? The get-together as part of MEDICA START-UP NIGHT. Women interested in attending the women leaders in healthcare session can find all the relevant details at the direct link to the forum programme at https://www.medica-tradefair.com/mif2.
More than just skin and bone: what bio-printers can produce
Wednesday also has an exciting onstage programme to offer. At 11 a.m., 3D printing will be the subject of discussion, before attention turns to innovative prosthetics, orthotics and similar applications. Nowadays, printing various biological materials, up to and including organs, is either already possible or in development. Manuel Figueruela, CEO of Regemat3D, will survey this landscape. Regemat3D designs, develops and manufactures 3D bio-printing systems and bio-reactors. In collaboration with more than 200 research groups in over 35 countries, they produce human tissue such as skin, cartilage, cornea, bone or heart tissue for implantation purposes. Robert Moebius is a lab manager at Biosaxony’s Medical Forge start-up programme, which works with industry partners such as HP. As O&P Global Leader, Ayelén Fernández from HP will be homing in on the field of orthopaedic technology and prosthetics.
From 1 p.m., the future of therapy will be the centre of attention at the forum. The series of talks will run the gamut from digital tools for home patient care to robot-assisted surgery, rehabilitation and assistive technologies.
The final day at the MEDICA INNOVATION FORUM will include an international flavour, with healthcare hubs from Finland, France, Germany, Taiwan and Japan presenting their organisations. This will also offer a perfect segue into the MEDICA START-UP PARK in the immediate vicinity of the forum stage. In this space, start-ups from all over the world – including Germany, Italy, India, Japan, Taiwan, Switzerland and the United States – will be putting their innovations for healthcare on show.
All the relevant information about MEDICA 2024, as well as all the themed forums, special shows and exhibiting organisations it will include, can be found online at https://www.medica-tradefair.com.